7 is shown a schematic representation of our results: ECFC-MMP12 recruited in tumor mass, by exploiting the CXCR4/SDF1 system, released the MMP12 anti-tumor uPAR degrading enzyme, thus impairing tumor growth and angiogenesis. This evidence concerns the gene CXCL12 and neoplasm.